Clinical Trial Update: Repeat Dose Safety and Efficacy Study for Compound to Treat Anemia [Phase 2]

View source ↗

Summary

GlaxoSmithKline completed a Phase 2 repeat-dose trial evaluating safety and efficacy of an investigational compound for anemia in kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Chronic Kidney Disease

Drugs mentioned

• Investigational compound for anemia in CKD

Snippet

Sponsor: GlaxoSmithKline | Conditions: Kidney Disease | Phase 2 | Status: COMPLETED